Literature DB >> 24215411

Advances in our understanding of the pathogenesis of Henoch-Schönlein purpura and the implications for improving its diagnosis.

Se Jin Park1, Jin-Soon Suh, Jun Ho Lee, Jung Won Lee, Seong Heon Kim, Kyoung Hee Han, Jae Il Shin.   

Abstract

Henoch-Schönlein purpura (HSP) is a leukocytoclastic vasculitis classically characterized by palpable purpura, arthritis, abdominal pain and renal disease. In this article, we summarize our current understanding of the pathogenesis of HSP and the implications for improving its diagnosis. Although the pathogenesis of HSP is not fully understood yet, exciting new information has emerged in recent years, leading to a better understanding of its pathogenesis. Here, we discuss genetic predisposition, immunoglobulins with a particular emphasis on IgA1, activated complements, cytokines and chemokines, abnormal coagulation and autoantibodies in the underlying pathogenic mechanisms. Finally, diagnostic criteria for HSP developed by institutions such as the American College of Rheumatology and the European League against Rheumatism/Paediatric Rheumatology European Society were proposed to improve early detection and diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24215411     DOI: 10.1586/1744666X.2013.850028

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  12 in total

Review 1.  Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature.

Authors:  Céline Roman; Bogdan Dima; Laurence Muyshont; Thierry Schurmans; Olivier Gilliaux
Journal:  Eur J Pediatr       Date:  2019-06-22       Impact factor: 3.183

2.  Efficacy and Safety of Tacrolimus in the Treatment of Pediatric Henoch-Schönlein Purpura Nephritis.

Authors:  Dengyan Wu; Rui Ma; Xingmin Wang; Yonghong Yang
Journal:  Paediatr Drugs       Date:  2022-05-05       Impact factor: 3.022

3.  Application value of laboratory indexes in the differential diagnosis of Henoch-Schoenlein purpura.

Authors:  W-X Shao; Q Ye; X-J Wang
Journal:  Z Rheumatol       Date:  2017-05       Impact factor: 1.372

Review 4.  Henoch-Schönlein purpura nephritis in children.

Authors:  Jean-Claude Davin; Rosanna Coppo
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

5.  Relationship between immune parameters and organ involvement in children with Henoch-Schonlein purpura.

Authors:  Yan-xiang Pan; Qing Ye; Wen-xia Shao; Shi-qiang Shang; Jian-hua Mao; Ting Zhang; Hong-qiang Shen; Ning Zhao
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

6.  [Comparison of age-based clinical and abnormal immune parameters in patients with Henoch-Schönlein purpura].

Authors:  N Zhang; P J Guo; P L Liu; H R Yang; J Xiao; X P Li; J B Huang; Y Z Zheng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-01-14

7.  Late Relapse of Henoch-Schönlein Purpura in an Adolescent Presenting as Severe Gastroduodenitis.

Authors:  Chiara Rubino; Monica Paci; Massimo Resti; Paolo Lionetti; Sandra Trapani
Journal:  Front Pediatr       Date:  2018-11-20       Impact factor: 3.418

8.  Treatment of refractory IgA vasculitis with dapsone: a systematic review.

Authors:  Keum Hwa Lee; Sung Hwi Hong; Jinhae Jun; Youngheun Jo; Woogyeong Jo; Dayeon Choi; Jeongho Joo; Guhyun Jung; Sunghee Ahn; Andreas Kronbichler; Michael Eisenhut; Jae Il Shin
Journal:  Clin Exp Pediatr       Date:  2019-09-24

9.  Beneficial effects of creatine phosphate sodium for the treatment of Henoch-Schönlein purpura in patients with early renal damage detected using urinary kidney injury molecule-1 levels.

Authors:  Jianjiang Zhang; Huiqin Zeng; Na Wang; Xiyan Tian; Wenjie Dou; Peipei Shi
Journal:  Eur J Pediatr       Date:  2015-07-30       Impact factor: 3.860

10.  Gastrointestinal involvement and its association with the risk for nephritis in IgA vasculitis.

Authors:  Mario Sestan; Nastasia Kifer; Marijan Frkovic; Matej Sapina; Sasa Srsen; Mateja Batnozic Varga; Aleksandar Ovuka; Martina Held; Ana Gudelj Gracanin; Ana Kozmar; Stela Bulimbasic; Marijana Coric; Gordana Laskarin; Alenka Gagro; Marija Jelusic
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-30       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.